Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005893
Filing Date
2025-08-15
Accepted
2025-08-15 16:24:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3368
  Complete submission text file 0001950047-25-005893.txt   4819
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Subject) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42179 | Film No.: 251224974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTIVA BIOTHERAPEUTICS, INC. 4747 EXECUTIVE DRIVE, SUITE 1150 SAN DIEGO CA 92121
Business Address
Aslan Fred (Reporting) CIK: 0001909362 (see all company filings)

Type: 144